Eligo Bioscience
PrivateLast Round
Grant
May 13, 2025
Total Funding Raised
$60.34M
Company Overview
Eligo Bioscience is a biotechnology company that develops antibiotics aimed at treating microbiome precision and bacteria-associated diseases through the use of engineered phage capsids and sequencing systems to create antimicrobials that target resistant pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eligo Bioscience Comps
Public and private peers based on sector, stage, and business model.
Eligo Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2025 | ||||
| Series B | Dec 5, 2023 | ||||
| Grant | May 1, 2019 | ||||
| Series A | Sep 26, 2017 | ||||
| Seed | Jul 8, 2015 |
Key People
Founding team and executive leadership
Eligo Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series B, Series A |
| European Commission | Grant |
| Bpifrance | Series B, Grant |
| Government of France | Grant |
| Sanofi Ventures | Series B |
| Bpifrance | Grant |
| Seventure Partners | Series A, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
Recognized as one of the World Economic Forum’s 30 Most Innovative Companies.
- May 13, 2025
Partnered with Biose Industries for microbial fermentation.
Eligo Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eligo Bioscience's valuation, stock price, and market status.
